MedPath

Difluocortolone

Generic Name
Difluocortolone
Drug Type
Small Molecule
Chemical Formula
C22H28F2O4
CAS Number
2607-06-9
Unique Ingredient Identifier
K253365DXI
Background

Difluocortolone is a potent topical corticosteroid. It is commonly used in dermatology for the reduction of inflammation and itching. It was submitted to the FDA in July 1984 by the pharmaceutical company Schering AG.

Indication

Difluocortolone is used as a topical treatment of the symptoms of inflammatory skin disorders like eczema, seborrheic eczema, lichen planus and psoriasis. All these disorders present as a common characteristic the occurrence of symptoms as itching, swelling, redness and scaling.

Associated Conditions
Aphthous Stomatitis, Dermatitis, Gingivitis, Infectious Periodontal Diseases, Periodontitis, Stomatitis, Corticosteroid-responsive dermatoses, Eczematous rash, Oral lesions

A Study to Learn More About the Relationship Between the Development of a Gap in the Upper Lip (Cleft Lip) or in the Roof of the Mouth (Cleft Palate) in Newborns and the Use of Glucocorticoids by the Mother During Pregnancy: a Meta-analysis

Completed
Conditions
Relationship Between the Exposure of Glucocorticoids During Pregnancy and Orofacial Cleft Development
Interventions
First Posted Date
2018-12-28
Last Posted Date
2020-04-01
Lead Sponsor
LEO Pharma
Target Recruit Count
99999
Registration Number
NCT03788863
Locations
🇩🇪

Many locations, Multiple Locations, Germany

© Copyright 2025. All Rights Reserved by MedPath